Time on boards
- Boards served
- 3
- Current seats
- 3
- Board service
- 6 years
- Director since
- 2023
6 years of board service in total across 3 boards, counting each seat separately. Longest: Liquidia Corporation, 3 years.
Liquidia Corporation
Director
Atea Pharmaceuticals Inc.
Director
Evommune Inc.
Director
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
| Date | Company | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Jul 7, 2026 | Evommune Inc. | Open-market purchase | +10,000 | $13.30 | $133,000 |
| Jun 16, 2026 | Liquidia Corporation | Grant or award | +5,882 | — | — |
| Jun 3, 2026 | Liquidia Corporation | Open-market sale | −10,000 | $54.80 | $548,000 |
| Jun 2, 2026 | Liquidia Corporation | Open-market sale | −5,000 | $56.00 | $280,000 |
| Jun 1, 2026 | Liquidia Corporation | Open-market sale | −15,000 | $60.22 | $903,300 |
| Jun 17, 2025 | Liquidia Corporation | Grant or award | +18,396 | — | — |
| Jun 20, 2024 | Liquidia Corporation | Grant or award | +20,359 | — | — |
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.